Role of fibric acid derivatives in the management of risk factors for coronary heart disease.
Després
Jean-Pierre
JP
Québec Heart Institute, Laval Hospital Research Center, Québec, Canada. jean-pierre.despres@crhl.ulaval.ca
Lemieux
Isabelle
I
Robins
Sander J
SJ
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002995:Clofibric Acid / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects; D012307:Risk Factors
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D002995:Clofibric Acid